Isopto Maxitrol ophthalmic suspension 5 ml

Isopto Maxitrol ophthalmic suspension 5 ml

Composition:

Each 1 ml of the drug contains:

Dexamethasone 1 mg

Polymyxin B 6000 IU

Neomycin 3.5 mg

Excipients:

Hydroxypropyl methylcellulose, sodium benzalkonium, disodium edetate, sodium chloride, polysorbate, sodium hydroxide, water for injection.

Properties:

A combination drug for topical use in ophthalmology.

Neomycin has a bactericidal effect by disrupting the synthesis of bacterial cell protein. It is active against Staphylococcus aureus, Corynebacterium diphteriae, Streptococcus viridans, Escherichia coli, Klebsiella pneumoniae, Proteus vulgaris, Aerobacter aerogenes and Haemophilus influenzae.

The mechanism of action of polymyxin B is mainly due to the blockade of the permeability of the cytoplasmic membrane of bacterial cells. It is active against Pseudomonas aeruginosa, Aerobacter aerogenes, Escherichia coli, Klebsiella pneumoniae and Koch-Weeks bacillus.

Dexamethasone is a glucocorticosteroid. It has anti-inflammatory, anti-allergic and desensitizing effects. It has an anti-exudative effect. Dexamethasone effectively suppresses inflammatory processes.

The combination of a glucocorticosteroid with antibiotics can reduce the risk of infection.

Indications:

Inflammatory conditions of the eye, accompanied by a superficial bacterial infection or risk of bacterial infection, amenable to treatment with corticosteroids, such as:

- inflammation of the conjunctiva of the eyelid or eyeball;

- inflammation of the cornea and anterior segment of the eye;

- chronic uveitis of the anterior segment of the eye;

Method of administration and dosage:

Apply externally 1-2 drops in each eye, can be applied up to 6 times a day.

Contraindications:

Hypersensitivity to the components of the combination.

Precautions:

Do not exceed the recommended doses. Prescribed with caution in glaucoma, cataracts.

Side effects:

Local: Allergic reactions, accompanied by itching and swelling of the eyelids, conjunctival hyperemia. Side effects caused by the steroid component: increased intraocular pressure with possible subsequent development of glaucoma, damage to the optic nerve and visual fields (if the drug is used for more than 10 days, intraocular pressure monitoring is necessary); posterior subcapsular cataract, delayed wound healing. Local application of steroids in diseases causing thinning of the cornea or sclera may lead to their perforation.

Secondary infection: The development of secondary infection is observed after the use of combination drugs containing GCS in combination with antibiotics.

Storage method:

Store at a temperature not exceeding 30 degrees.

Packaging:

A cardboard box contains a plastic bottle of 5 ml, paper instructions.